European Archives - Page 48 of 1108 - European Medical Journal

Epstein-Barr Virus as a Risk Factor for Multiple Sclerosis: New Insights

Groundbreaking research links EBV antibodies to MS via brain protein attacks. Genetic risks amplify danger, paving the way for targeted therapies.

Cancer Mortality Higher in Patients with Rheumatoid Arthritis

While patients with rheumatoid arthritis have a lower overall cancer incidence rate, they face higher post-cancer mortality.

Gut Microbiota Predicts Lung Cancer Treatment Outcomes

Gut microbiota composition may influence the efficacy and safety of chemo-immunotherapy in advanced non-small cell lung cancer.

RSV Resistance to Nirsevimab Remains Rare in Infants

A large-scale genomic surveillance study has found that resistance to nirsevimab in infants remains rare despite widespread use.

Garlic Intake May Increase Gastritis Risk in H. pylori-Infected Individuals

Garlic intake has long been touted for its health benefits, but new research suggests it may increase the risk of atrophic gastritis in individuals with H. pylori infections.

New Topical Treatment for Primary Axillary Hyperhidrosis

The study also highlighted the psychological burden of hyperhidrosis, linking the condition to increased anxiety, depression, and impaired quality of life.

What are the Key Predictors of Adverse Cardiovascular Outcomes with SCAD?

SCAD study flags risky blood thinners, fibromuscular dysplasia as predictors of heart complications. Urges treatment rethink.

High-Protein Diets Improve Glycaemic Control in Type 2 Diabetes

A high-protein vegan diet rich in mycoprotein improves glycaemic control in Type 2 diabetes, comparable to an omnivorous diet.

New Guidelines Improve Anaphylaxis Diagnosis and Treatment

The Clinical Support Tool is a significant advancement, integrating clear clinical criteria and epinephrine treatment guidelines.

Ultrasound Neuromodulation Offers Hope for Younger Patients with Alzheimer’s

Ultrasound therapy boosts cognition in younger Alzheimer’s patients. Study highlights TPS as a potential add-on treatment.